Developing science,
delivering therapies

4d

Our company

We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Our approach
developing-science

Developing science

From asthma to cancer, we conduct world-leading research to identify live biotherapeutics with drug-like functionality to treat a range of diseases.

What we do
delivering-therapies

Delivering therapies

We are uniquely positioned to rapidly translate our research into regulated, safe and efficacious therapies for patients.

Find out more

News

Oncology clinical study approved

MHRA clears CTA for MRx0518 Phase Ib study in solid tumours

21/05/2018

READ RNS

Merck clinical collaboration

4D and MSD to collaborate on clinical study to assess MRx0518 in combination with Keytruda

07/06/2018

Read RNS